The purpose of this role is to evaluate cancer neoantigens in oncogenic mouse models, in order to develop novel peptide vaccines.
The Kids Research Institute Australia's Cancer Immunology group is focussed on harnessing the power of the immune system to eradicate primary and advanced cancer, particularly immune-based therapies targeting the activity of helper and killer T cells. One of our key projects is the development of a novel therapeutic peptide vaccine strategy to generate T cell immunity directed against mutated cancer antigens, which has the potential to have wide-ranging applications in the field of T-cell directed vaccination and personalized medicine.
We are seeking a highly motivated, ambitious and skilled individual to be part of an energetic and interdisciplinary research team. The dynamic working environment requires candidates to have strong analytical and conceptualisation skills and to work productively in a team setting. Applicants must have solid experience in tissue culture, in vivo techniques, flow cytometry, real-time PCR methods and molecular biology. Demonstrated skills in oncology models, histology, confocal microscopy, and luminescence-based in vivo imaging would be advantageous.
How to apply:
Applicants can read the job description here. Applications MUST include a statement addressing the selection criteria, the applicant’s curriculum vitae and the contact details of two current referees. Applicants not addressing the selection criteria will not be considered for this position.
Submit your application along with a covering letter to applications@telethonkids.org.au Please quote the position title in the subject heading of your email application.
For further information, please e-mail Dr Jason Waithman.
Closing date: 5:00pm 21st April, 2017